Point mutations within exon 14, such as Y1003X or D1010X, which cause the MET overexpression and lead to disrupt normal signaling pathways, promote uncontrolled cell growth and proliferation, contributing to the development and progression of lung cancer, particularly non-small cell lung cancer (NSCLC) [2]. This evidence concerns the gene MET and non-small cell lung carcinoma.